Regulation of sensitivity to TRAIL by the PTEN tumor suppressor. (Q35756915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

review article

1 reference

title

Regulation of sensitivity to TRAIL by the PTEN tumor suppressor (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Xiu-Juan Yuan

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Yuanbo Liu

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Samarpan Majumder

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Terrence D Lewis

series ordinal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

published in

Vitamins and Hormones

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

page(s)

409-426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15110188%20AND%20SRC:MED&resulttype=core&format=json

Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity

27 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Apoptosis control by death and decoy receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Safety and antitumor activity of recombinant soluble Apo2 ligand

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Constitutively active Akt1 protects HL60 leukemia cells from TRAIL-induced apoptosis through a mechanism involving NF-kappaB activation and cFLIP(L) up-regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

PED/PEA-15: an anti-apoptotic molecule that regulates FAS/TNFR1-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Cellular survival: a play in three Akts

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Post-translational modification of Bid has differential effects on its susceptibility to cleavage by caspase 8 or caspase 3.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Pten is essential for embryonic development and tumour suppression

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Acute pathological effects on rats of orally administered wortmannin-containing preparations and purified wortmannin from Fusarium oxysporum

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

How melanoma cells evade trail-induced apoptosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

PTEN/MMAC1/TEP1 suppresses the tumorigenicity and induces G1 cell cycle arrest in human glioblastoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Akt suppresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-kappaB.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

PTEN blocks tumor necrosis factor-induced NF-kappa B-dependent transcription by inhibiting the transactivation potential of the p65 subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Activation of NF-kappaB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Intracellular regulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human multiple myeloma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Biologic sequelae of nuclear factor-kappaB blockade in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

TRAIL/Apo2L ligand selectively induces apoptosis and overcomes drug resistance in multiple myeloma: therapeutic applications

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Elevated AKT activity protects the prostate cancer cell line LNCaP from TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

NF-kappaB as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

NF-kappaB activation by tumour necrosis factor requires the Akt serine-threonine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Regulation of Akt by EGF-R inhibitors, a possible mechanism of EGF-R inhibitor-enhanced TRAIL-induced apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

NF-kappaB is a target of AKT in anti-apoptotic PDGF signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

The proteasome inhibitor PS-341 sensitizes neoplastic cells to TRAIL-mediated apoptosis by reducing levels of c-FLIP.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Control of TRAIL-Induced Apoptosis by a Family of Signaling and Decoy Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Activation of phosphatidylinositol 3-kinase in response to interleukin-1 leads to phosphorylation and activation of the NF-kappaB p65/RelA subunit

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Living with lethal PIP3 levels: viability of flies lacking PTEN restored by a PH domain mutation in Akt/PKB.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

MAPK/ERK overrides the apoptotic signaling from Fas, TNF, and TRAIL receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

CD95 and TRAIL receptor-mediated activation of protein kinase C and NF-kappaB contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Protein kinase B/Akt binds and phosphorylates PED/PEA-15, stabilizing its antiapoptotic action

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Identification and characterization of a new member of the TNF family that induces apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

The PTEN/MMAC1 tumor suppressor phosphatase functions as a negative regulator of the phosphoinositide 3-kinase/Akt pathway

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

PTEN sensitizes prostate cancer cells to death receptor-mediated and drug-induced apoptosis through a FADD-dependent pathway.

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0083-6729%2804%2967021-X

7 January 2021

10.1016/S0083-6729(04)67021-X

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lqjlyijdkreepovhrcys3it4im

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_lqjlyijdkreepovhrcys3it4im

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/lqjlyijdkreepovhrcys3it4im

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/lqjlyijdkreepovhrcys3it4im

1 reference

30 July 2022